07 Jan 2001

Tannalbin® (Tannalbin® Kapseln) - Deutschland

Tannalbin® Description, Presentation and Dosage

Tannalbin® Description

Tannalbin® Drug Class Description


Tannalbin® Drug Description

1 Kps. enth.: Tanninalbuminat 250 mg.

Tannalbin® Generic Name

Tannalbin® Kapseln

Tannalbin® Presentation

Tannalbin® Presentation


Tannalbin® Manufacturer


Related Learning Zones

Anti-Infectives Knowledge Network CDI

Anti-Infectives Knowledge Network CDI

The Anti-Infectives Knowledge Network – Clostridium difficile infection (AIKN-CDI), an initiative by Astellas Pharma EMEA, shares the expertise and experience of thought leaders in the therapy area of anti-infectives, with a particular focus on C. difficile infection.

Recent updates include ECCMID, ICDS, EBMT and ISICEM 2015 slide decks and congress reports, an infographic on ‘CDI in the EU’, data from the largest ever European clinician consensus report, as well as congress overviews, news reports and CDI expert perspectives.

Anti-Infectives Knowledge Network IFI

Anti-Infectives Knowledge Network IFI

The Anti-Infectives Knowledge Network – Invasive Fungal Infections (AIKN-IFI), an initiative by Astellas Pharma EMEA, assembles the experience and expertise of a number of thought leaders in the area of anti-infectives, with a particular focus on invasive fungal infections.

This free resource is regularly updated with congress highlights, industry reports, policy changes, clinical guidelines and downloadable material from major medical events, so make sure you return often.

August 2015 MYC/15/0023/EUa

Tannalbin® Dosage

Tannalbin® Adult Dosage

Gelatine, Farbstoffe E 171, E 172.

Tannalbin® Child Dosage

Tannalbin® Tabletten
Zus.: 1 Tbl. enth.: Tanninalbuminat 500 mg.
Weit. Bestandteile: Gelatine, hochdisperses Siliciumdioxid, Stearinsäure.

Tannalbin® Precautions, Reactions and Contraindications

Tannalbin® Special Precautions

Tannalbin® Special Precautions

Überempfindlichkeit gegenüber Ovalbuminanteil.

Tannalbin® Adverse Reactions

Tannalbin® Adverse Reactions

Strenge Ind.-Stellung in den ersten 3 Mon. Gr 2 .

Related Drugs - Gastroenterology

Back to top